BioSpace News Archive

Biotech Bay

California Family Physicians Applaud Expansion of COVID-19 Vaccine to Adolescents

Yesterday, California authorized the Pfizer vaccine for kids ages 12-15. The move came after a group of experts from California and other Western states independently reviewed the U.S. Food and Drug Administration’s and the Advisory Committee on Immunization Practices decision to approve the vaccine for that age group.

May 15, 2021
·
2 min read
Pharm Country

REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented at the ACC’s 70th Annual Scientific Session

Post hoc analyses by estimated on-treatment serum EPA levels in the VASCEPA group suggest potentially reduced incidence of new heart failure and new heart failure requiring hospitalization with higher achieved serum EPA levels

May 15, 2021
·
15 min read
Policy

Statement from the Chief Public Health Officer of Canada on May 15, 2021

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

May 15, 2021
·
7 min read
Drug Development

Bristol Myers Squibb Presents Late-Breaking Phase 3 Data Demonstrating Health Status Benefits of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy at American College of Cardiology’s 70th Annual Scientific Session

Mavacamten, a potential first-in-class cardiac myosin inhibitor for patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), showed improvement in health status compared to placebo at 30 weeks in EXPLORER-HCM trial

May 15, 2021
·
7 min read